Viewing StudyNCT00014755



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00014755
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 2001-04-10

Brief Title: Phase I Pilot Study of Total-Body Irradiation Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis
Sponsor:
Organization: Office of Rare Diseases ORD

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 35
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: